4//SEC Filing
Waldegrave William A. 4
Accession 0000899243-19-006330
CIK 0001351288other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 9:05 PM ET
Size
12.5 KB
Accession
0000899243-19-006330
Insider Transaction Report
Form 4
Waldegrave William A.
Director
Transactions
- Award
Stock Options
2019-03-01+16,548→ 16,548 totalExercise: $14.33From: 2022-03-01Exp: 2029-03-01→ Ordinary Shares (16,548 underlying) - Award
Stock Options
2019-03-01+3,144→ 3,144 totalExercise: $0.00From: 2020-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying) - Award
Stock Options
2019-03-01+3,144→ 3,144 totalExercise: $0.00From: 2022-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying) - Award
Stock Options
2019-03-01+3,144→ 3,144 totalExercise: $0.00From: 2021-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying)
Footnotes (4)
- [F1]Granted pursuant to the Issuer's Long-Term Incentive Plan.
- [F2]The reported options are options to purchase American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- [F3]The exercise price reported is price per ordinary share converted from price per ADS ($172.01).
- [F4]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.
Documents
Issuer
GW PHARMACEUTICALS PLC
CIK 0001351288
Entity typeother
Related Parties
1- filerCIK 0001754145
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 9:05 PM ET
- Size
- 12.5 KB